GO
Loading...

Endo Health Solutions Inc

  • Lumber Liquidators and Endo are big market movers Monday, 2 Mar 2015 | 4:49 PM ET

    NEW YORK— Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:. Freescale Semiconductor Ltd., up $4.25 to $40.36. Lumber Liquidators Holdings Inc., down $13.03 to $38.83.

  • *Markit manufacturing hits 4- month high. NEW YORK, March 2- U.S. stocks advanced on Monday, with the Nasdaq nudging above the 5,000 mark for the first time in 15 years, as a round of mixed data pointed to a slowly accelerating economy. Fundamentals are good enough at technology companies, the biggest group on Nasdaq, that the index should be able to stay above 5000, said...

  • NEW YORK— Medical device maker Boston Scientific said Monday it will pay $1.6 billion to buy the men's health and prostate health business of Endo International. Boston Scientific said it is gaining treatments for enlarged prostate, urinary incontinence caused by stress, and erectile dysfunction, and said the business has about $130 million in adjusted...

  • *Markit manufacturing hits 4- month high, ISM hits 13- month low. NEW YORK, March 2- U.S. stocks advanced on Monday to push the Nasdaq above the 5,000 mark for the first time in fifteen years, as a round of mixed data pointed to a slowly accelerating economy. "Five thousand on the Nasdaq, it's been a long time coming," said Peter Kenny, chief market strategist at Clearpool...

  • *Manufacturing data expected from Markit, ISM. *HP to buy Aruba Networks. At 9:45 a.m., data will be released on the manufacturing sector by financial data firm Markit, following shortly afterwards by the Institute for Supply Management's reading on the manufacturing sector at 10:00 a.m..

  • *Manufacturing data expected from Markit, ISM. *HP to buy Aruba Networks. At 9:45 a.m., data will be released on the manufacturing sector by financial data firm Markit, following shortly afterwards by the Institute for Supply Management's reading on the manufacturing sector at 10:00 a.m..

  • *Manufacturing data expected from Markit, ISM. *Investors will also eye data on the manufacturing sector, with financial data firm Markit final Manufacturing Purchasing Managers Index expected at 9:45 a.m.. The Institute for Supply Management's reading on the manufacturing sector is scheduled for release at 10:00 a.m..

  • Endo reports 4Q loss Monday, 2 Mar 2015 | 7:21 AM ET

    DUBLIN 4, Ireland _ Endo International PLC on Monday reported a loss of $53.5 million in its fourth quarter. The Dublin 4, Ireland- based company said it had a loss of 35 cents per share. The average estimate of analysts surveyed by Zacks Investment Research was for earnings of $1.13 per share.

  • NEW YORK, Feb 20- Valeant Pharmaceuticals International Inc is close to a deal to acquire bowel drug maker Salix Pharmaceuticals Ltd for around $160 per share, according to a person directly familiar with the matter. A deal of that size would be the largest ever for Valeant, which lost a takeover contest for Allergan Inc last year. The usually acquisitive Valeant...

  • Jan 26- The U.S. Food and Drug Administration said it approved Teva Pharmaceutical Industries Ltd's generic version of AstraZeneca Plc's blockbuster heartburn drug Nexium, the agency's first such approval for the drug. Nexium raked in about $1.9 billion in global sales in the first half of 2014, according to AstraZeneca's latest earnings statement.

  • Nov 20- A U.S. court has denied a request by Indian drugmaker Ranbaxy Laboratories Ltd to stop competitors from launching copies of AstraZeneca Plc's heartburn pill Nexium and Roche's antiviral, a court filing showed. Ranbaxy had filed a lawsuit against the U.S. Food and Drug Administration last week for revoking tentative approvals it gave the company to make...

  • Nov 20- A U.S. court has denied a request by Indian drugmaker Ranbaxy Laboratories Ltd to stop competitors from launching copies of AstraZeneca Plc's heartburn pill Nexium and Roche's antiviral Valcyte, a court filing showed. Ranbaxy had sought the restraining order against Dr Reddy's Laboratories and U.S. firm Endo International Plc in a lawsuit it filed...

  • Nov 5- Endo International Plc raised its 2014 forecast for the third time and reported a better-than-expected quarterly profit, its recent acquisitions helping boost generic drug sales in the United States by nearly 74 percent. The Dublin- based maker of drugs and medical devices, which last month clinched a deal to buy Auxilium Pharmaceuticals Inc, raised its...

  • Nov 5- Endo International Plc, which is acquiring Auxilium Pharmaceuticals Inc, reported a better-than-expected quarterly profit due to a nearly 74 percent jump in sales of its generic drugs in the United States. The Dublin- based company's adjusted net income rose to $182.3 million in the quarter ended Sept. 30, from $160.7 million a year earlier.

  • Nov 3- Boston Scientific Corp on Monday was set to face its first federal trials in two courts over claims from women who say they were injured by the company's transvaginal mesh devices. Boston Scientific has been hit with more than 23,000 suits in U.S. state and federal courts over the devices in the six years since concerns were first publicly raised over the...

  • *Endo offers $33.25/ share for Auxilium. Oct 9- Endo International Plc brought a successful end to its month-long pursuit of Auxilium Pharmaceuticals Inc, with the smaller rival choosing a sweetened offer over its agreement to buy Canadian eye-drug maker QLT Inc.. "Endo recognizes the value inherent to Xiaflex, given the drug's potential in multiple additional...

  • NEW YORK, Oct 9- U.S. stock index futures pointed to a lower Wall Street open on Thursday, with earlier gains erased as concerns about global growth spurred investors to take profit following a massive advance in the previous session. The third-quarter earnings season got off to a strong start, with both Alcoa Inc and PepsiCo Inc rallying in premarket trading...

  • Oct 9- Auxilium Pharmaceuticals Inc agreed to be bought by Endo International Plc for $1.67 billion and terminated its deal to buy Canadian eye-drug maker QLT Inc.. Endo moved its tax domicile to Ireland from Pennsylvania last year when it bought Canadian drugmaker Paladin Labs Inc.. Citi is Endo's financial adviser and Sullivan& Cromwell LLP is its legal...

  • NEW YORK, Oct 9- Alcoa Inc and PepsiCo Inc were among Thursday's biggest premarket movers, with both rallying on strong results. Aluminum maker Alcoa jumped 1.6 percent to $16.32, a day after its third-quarter earnings beat expectations on higher aluminum prices and lower costs. The results contributed to a positive tone on Wall Street as Alcoa was one of the...

  • Oct 9- Endo International Plc said it would buy Auxilium Pharmaceuticals Inc in a deal valued at $2.6 billion, including the repayment and assumption of debt. Endo's offer of $33.25 per share represents a premium of about 12 percent to Auxilium's Wednesday close and is higher than Endo's previous offer of $28.10. As part of the deal, Auxilium terminated its...